RecruitingNot ApplicableNCT07227805

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes

Sponsor

Medtronic MiniMed, Inc.

Enrollment

116 participants

Start Date

Jul 19, 2026

Study Type

INTERVENTIONAL

Conditions

Diabetes (Insulin-requiring, Type 1 or Type 2)

Summary

This study will demonstrate the safety and performance of the Novel Medtronic Experimental Automated Insulin Delivery system named MiniMed™ NMX8 system in people living with insulin-requiring diabetes in comparison with the MiniMed™ 780G system.

Eligibility

Min Age: 2 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called 780G and a medical device called NMX8 for people with diabetes (insulin-requiring, type 1 or type 2). The study is currently recruiting participants at 9 locations. People eligible for this study include aged 2 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENMX8

Subjects will start using the MiniMed™ NMX8 system for 12 weeks

DEVICE780G

Subjects will continue to use the MiniMed™ 780G for 12 weeks

Locations(9)

Universitair Ziekenhuis Antwerpen

Antwerp, Belgium

Cliniques Universitaires de Bruxelles - Hôpital Erasme

Brussels, Belgium

UZ Leuven

Leuven, Belgium

UZ Leuven

Leuven, Belgium

Steno Diabetes Center Aarhus

Aarhus, Denmark

Steno Diabetes Center Copenhagen

Herlev, Denmark

Sheba Medical Center, Edmond and Lily Safra Children's Hospital

Ramat Gan, Israel

Sheba Medical Center

Ramat Gan, Israel

University Medical Centre Ljubljana

Ljubljana, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07227805

Related Trials

Integrating New Skills Into Diabetes Education With CGM

NCT074632091 location

MiniMed Fit Payload Wear Pediatric Study

NCT076751615 locations

Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy.

NCT076117211 location

MiniMed Fit Payload Wear Study

NCT074081414 locations

Evaluation of a Mobile AI-powered Decision Support System for Insulin Dosing and Glucose Prediction in Type 1 Diabetes: The glUCModel Clinical Trial Protocol

NCT073047782 locations